Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Subst Abuse Treat. 2016 May 9;67:30–37. doi: 10.1016/j.jsat.2016.05.001

Table 1.

Descriptive characteristics of participants at baseline.

%§
Participants (N) 443
Age (Median [IQR]) 47 [40, 52]
Male gender 63.2
Completed High School 52.0
Aboriginal 32.5
White 63.0
Ever been homeless 92.8
Ever been in jail 39.5
HIV+ 37.7
HCV+ 92.1
Any physical disability 81.3
Ever had mental illness diagnosed 62.3
Ever attempted suicide 17.9
Age of first injection drug use (Median [IQR]) 18 [15, 25]
Ever overdosed 63.9
Longitudinal illicit opioid use
 Reported at every follow-up 24.6
 Reported at one follow-up or more 69.1
 Not reported at any follow-up 30.9
Longitudinal stimulant use
 Reported at every follow-up 13.5
 Reported at one follow-up or more 50.1
 Not reported at any follow-up 49.9
Longitudinal OAT receipt
 Reported at every follow-up 61.6
 Reported at one follow-up or more 90.5
 Not reported at any follow-up 9.5
§

Percentage of study sample, unless otherwise noted.

IQR: interquartile range

HIV+: Human Immunodeficiency Virus positive

HCV+: Hepatitis C positive

Including heroin, morphine and prescription opioids

Including crack, cocaine, speed and methamphetamine